Lecanemab reduced decline in memory and thinking skills by 27% over 18 months in a trial of 1,800 people with early-stage Alzheimer’s.
It is the only drug to treat the underlying disease, not just temporarily manage symptoms. It may be available to British patients with early-stage Alzheimer’s in two to three years.
Bu hikaye Daily Mirror UK dergisinin September 29, 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Daily Mirror UK dergisinin September 29, 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Arsenal expect results & trophies. Now Arteta will start to be judged
TODAY MARKS FIVE YEARS SINCE MIKEL TOOK CHARGE. THERE'S BEEN PROGRESS AND REBUILDING BUT FANS WILL NOW START WANTING TO SEE MAJOR SILVERWARE
WAD A JOB
Dyche to stay at Goodison after keeping Everton in the Prem while making big cuts
STARE WAY TO HELL
Fury launches verbal assault on Usyk after both champ and challenger take part in incredible 11-MINUTE face-off
OPEN AND SHUT CASE
Draper saves himself for Aussie
RED BULL GIVES LIAMS WINGS
F1 nod for Lawson to team up with champ Verstappen
Man held for 'mass shooting plot' with killer, 15
Pair were planning attack, cops say
I'm older, braver..& don't care what people think
TAMZIN OUTHWAITE - Soap favourite shines on Strictly Christmas special
Geordie sure
Terminally ill Utd fan gives boss team tips
Ashes, a handprint..this is all we have left
Sister of victim faces jailed double-killers
FLUNAMI
41% rise in hospital cases..and worsening
